Literature DB >> 15385450

Enteric pathogens as vaccine vectors for foreign antigen delivery.

Camille N Kotton1, Elizabeth L Hohmann.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15385450      PMCID: PMC517600          DOI: 10.1128/IAI.72.10.5535-5547.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  141 in total

Review 1.  PhoE protein as a carrier for foreign epitopes.

Authors:  R Janssen; J Tommassen
Journal:  Int Rev Immunol       Date:  1994       Impact factor: 5.311

2.  Utilization of soluble fusion proteins for induction of T cell proliferation.

Authors:  D A Kirschmann; P A De Ciechi; C P Bono; M L Zacheis; B D Schwartz; S L Woulfe
Journal:  Cell Immunol       Date:  1995-02       Impact factor: 4.868

3.  Adaptation of Escherichia coli growth rates to the presence of pBR322.

Authors:  P J McDermott; P Gowland; P C Gowland
Journal:  Lett Appl Microbiol       Date:  1993-09       Impact factor: 2.858

4.  Specific adhesion and hydrolysis of cellulose by intact Escherichia coli expressing surface anchored cellulase or cellulose binding domains.

Authors:  J A Francisco; C Stathopoulos; R A Warren; D G Kilburn; G Georgiou
Journal:  Biotechnology (N Y)       Date:  1993-04

Review 5.  Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development.

Authors:  S H Kaufmann; J Hess
Journal:  Immunol Lett       Date:  1999-01       Impact factor: 3.685

6.  Temperature and growth rate effects on the hok/sok killer locus for enhanced plasmid stability.

Authors:  K Wu; D Jahng; T K Wood
Journal:  Biotechnol Prog       Date:  1994 Nov-Dec

7.  Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.

Authors:  F R Noriega; J Y Wang; G Losonsky; D R Maneval; D M Hone; M M Levine
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

Authors:  C Gonzalez; D Hone; F R Noriega; C O Tacket; J R Davis; G Losonsky; J P Nataro; S Hoffman; A Malik; E Nardin; M B Sztein; D G Heppner; T R Fouts; A Isibasi; M M Levine
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

9.  Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface.

Authors:  J A Francisco; R Campbell; B L Iverson; G Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

10.  Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.

Authors:  E K Jagusztyn-Krynicka; J E Clark-Curtiss; R Curtiss
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more
  37 in total

Review 1.  Sampling of the intestinal microbiota by epithelial M cells.

Authors:  Joseph M Pickard; Alexander V Chervonsky
Journal:  Curr Gastroenterol Rep       Date:  2010-10

2.  Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.

Authors:  Li-Mei Chen; Gabriel Briones; Ruben O Donis; Jorge E Galán
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.

Authors:  Daniela I M Loeffler; Christoph U Schoen; Werner Goebel; Sabine Pilgrim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  From allergen to oral vaccine carrier: A new face of ragweed pollen.

Authors:  Md Jasim Uddin; Harvinder Singh Gill
Journal:  Int J Pharm       Date:  2018-05-03       Impact factor: 5.875

5.  An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers.

Authors:  Mary-Jane Lombardo; Jane Michalski; Hector Martinez-Wilson; Cara Morin; Tamara Hilton; Carlos G Osorio; James P Nataro; Carol O Tacket; Andrew Camilli; James B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

6.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

7.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

8.  Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination.

Authors:  Fengling Luo; Yong Feng; Min Liu; Pingfei Li; Qin Pan; Victor Tunje Jeza; Bing Xia; Jianguo Wu; Xiao-Lian Zhang
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

9.  Vaxvec: The first web-based recombinant vaccine vector database and its data analysis.

Authors:  Shunzhou Deng; Carly Martin; Rasika Patil; Felix Zhu; Bin Zhao; Zuoshuang Xiang; Yongqun He
Journal:  Vaccine       Date:  2015-09-25       Impact factor: 3.641

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.